Hormones and Cancer

Aims & Scope

Hormones and Cancer is a unique multidisciplinary translational journal featuring basic science, pre-clinical, epidemiological, and clinical research papers.

It covers all aspects of the interface of Endocrinology and Oncology.

Thus, the journal covers two main areas of research: Endocrine tumors (benign & malignant tumors of hormone secreting endocrine organs) and the effects of hormones on any type of tumor.

We welcome all types of studies related to these fields, but our particular attention is on translational aspects of research.

In addition to basic, pre-clinical, and epidemiological studies, we encourage submission of clinical studies including those that comprise small series of tumors in rare endocrine neoplasias and/or negative or confirmatory results provided that they significantly enhance our understanding of endocrine aspects of oncology.

The journal does not publish case studies.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Neuroscience, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer

  Citation: 278

  Authors: Leo F., Jason G., Yuping, Tamir S., Hugh S.

• Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions

  Citation: 240

  Authors: Adriana C., Zannel, Kathryn A., Jason

• Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

  Citation: 229

  Authors: Masis, Kristen, Steven, Jacob, Yi, Donald J., Suzanne D., Russell Z.

• RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review

  Citation: 146

  Authors: Gowri, Solomon F. D.

• Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers

  Citation: 142

  Authors: Anieta M., Scooter, Michael B., Maxime P., Marion E. Meijer-Van, Andreas, Marinus R., Heinz, Lodewyk, Brian, Kathryn P., John A., Reuben S., John W. M.

• MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer

  Citation: 116

  Authors: Dawn R., Diana M., Erin N., Nicole S., Erin L., Kelly, Anthony, Douglas, Jennifer K.

• Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

  Citation: 99

  Authors: Mary, Emmanuel S., Jun

• The Weiss Score and Beyond—Histopathology for Adrenocortical Carcinoma

  Citation: 92

  Authors: Mauro, Rossella, Eleonora, Marco, Jerome, Frederique

• GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast

  Citation: 91

  Authors: Allison L., Eric R., Helen J.

• Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism

  Citation: 90

  Authors: Lee F., Tobias, William D., Alberto, Patricia, Robert, Richard P., Tobias